Publications

5491 Results

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Bronchoalveolar Carcinoma of the Lung (Cohort 12)

Authors
Y Chae;M Othus;S Patel;D Gerber;T Tanvetyanon;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;C Blanke;R Kurzrock
Journal / Conference
WCLC Annual Meeting (September 9-12, 2023, Singapore), poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers (SWOG S1815; NCT#03768414)

Authors
R Shroff;K Guthrie;A Scott;M Borad;L Goff;K Matin;A Mahipal;A Kalyan;M Javle;C Aghajanian;B Tan;P Cheema;A Patel;R Iyer;R Kelley;J Thumar;A El-Khoueiry;EG Chiorean;H Hochster;PA Philip
Journal / Conference
J Clin Oncol 41, 2023 (suppl 4; abstr LBA490); ASCO GI Cancers Symposium (January 19-21, 2023, San Francisco, CA), oral
Year
2023
Research Committee(s)
Gastrointestinal
Study Number(s)
S1815

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The non-epithelial ovarian tumor cohort #13

Authors
Y Chae;M Othus;S Patel;K Wilkinson;E Whitman-Purves;J Lea;J Schallenkamp;N Adra;L Appleman;M Alden;J Thomes Pepin;J Ellerton;A Poklepovic;A Walter;M Rampurwala;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
AACR Annual Meeting (April 14-19, 2023, Orlando, FL, poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The small cell carcinoma of the ovary, hypercalcemic type cohort #49

Authors
Y Chae;M Othus;S Patel;R Aljumaily;K Win;T Pejovic;S Thomas;L Il-Young Chung;C McLeod;H Chen;E Sharon;H Streicher;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
AACR Annual Meeting (April 14-19, 2023, Orlando, FL, poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Adjuvant everolimus in patients (pts) with completely resected very high-risk renal cell cancer (RCC) and clear cell histology: results from the phase III placebo-controlled SWOG S0931 (EVEREST) trial

Authors
PN Lara;C Tangen;E Heath;M Stein;M Meng;A Alva;S Pal;I Puzanov;J Clark;T Choueiri;N Agarwal;R Uzzo;N Haas;M Plets;U Vaishampayan;B Shuch;IM Thompson;C Ryan
Journal / Conference
Annals of Oncology VOLUME 34, SUPPLEMENT 2, S1015; ESMO (October 20-24, 2023, Madrid, Spain), poster
Year
2023
Research Committee(s)
Genitourinary
Study Number(s)
S0931

Clinical outcomes and translational analysis of DART S1609: the thyroid cancer cohort; PD-1+ PD-L1+ TIL correlated with favorable survival

Authors
YK Chae;Y Lu;S Patel;C Rodriguez;A Onitilo;A Mattour;I Rybkin;S Fenton;L Il-Young Chung;H Kim;M Othus;E Parra;J Zhang;L Gomez;C Fernandez;L Soto;H Chen;G Manyam;D Duose;R Luthra;J Zhang;G Al-Atrash;I Wistuba;J Lee;J Zhang;C Haymaker;C McLeod;H Chen;E Sharon;C Ryan;G Lopez;M Plets;CD Blanke;R Kurzrock
Journal / Conference
SITC Annual Meeting (Nov. 1-5, 2023, San Diego, CA), poster
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency

Authors
S Stecklein;W Barlow;L Pusztai;K Timms;R Kennedy;G Logan;R Seitz;S Badve;Y Gokmen-Polar;P Porter;H Linden;D Tripathy;G Hortobagyi;A Godwin;A Godwin;A Thompson;D Hayes;P Sharma
Journal / Conference
JCO Precision Oncology Sep:7:e2300197. doi: 10.1200/PO.23.00197
Year
2023
Research Committee(s)
Breast
PMID
PMID37972336
PMC
PMC10681491
Study Number(s)
SWOG-9313

Mixed-methods analysis of physician genomic confidence in the pre-implementation phase of the cluster randomized trial evaluating genomic tumor boards (SWOG S2108CD, NCT05455606)

Authors
M Trivedi;J Rueter;J Unger;K Arnold;S Colby;A Michel;A Taboada;L Graham;K Reed;J Fischer;B Symington;S Ramsey;D Hershman
Journal / Conference
ASCO Quality Care Symposium (October 27-28, 2023, Boston, MA, poster; JCO Oncol Pract 19, 2023 (suppl 11; abstr 439)
Year
2023
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S2108CD

Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients

Authors
E Pogosova-Agadjanyan;X Hua;M Othus;F Appelbaum;T Chauncey;H Erba;M Fitzgibbon;J Godwin;I Jenkins;M Fang;A Moseley;J Naru;J Radich;B Willborg;C Willman;F Wu;S Meshichi;D Stirewalt
Journal / Conference
Biomarker Research Mar 16;11(1):31. doi: 10.1186/s40364-023-00461-0
Year
2023
Research Committee(s)
Leukemia
PMID
PMID36927800
PMC
PMC10022072
Study Number(s)
S0106, S0112, SWOG-9031, SWOG-9333

Clinical trial design change implementation for inclusive studies

Authors
M Espinoza Gutarra;J Aiello;R Orlowski;S Ailawadhi
Journal / Conference
Lancet Hematology Dec;10(12):e953-e954. doi: 10.1016/S2352-3026(23)00336-8
Year
2023
Research Committee(s)
Myeloma
PMID
PMID38030317
Study Number(s)
S2209